(Q28195662)

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

24 December 2023

Carol M Mangione

0 references

author name string

Debra Saliba

0 references

Arlene F. Brown

1 reference

Europe PubMed Central

PubMed publication ID

12694461

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694461

24 December 2023

Catherine A. Sarkisian

1 reference

Europe PubMed Central

PubMed publication ID

12694461

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694461

24 December 2023

California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes

1 reference

Europe PubMed Central

PubMed publication ID

12694461

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694461

full work available at URL

24 December 2023

language of work or name

English

0 references

publication date

May 2003

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1532-5415.51.5s.1.x

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1532-5415.51.5s.1.x/fullpdf

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Journal of the American Geriatrics Society

24 December 2023

published in

0 references

volume

0 references

issue

5 Suppl Guidelines

0 references

page(s)

S265-80

0 references

cites work

Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

A SELF-RATING DEPRESSION SCALE

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Drug-induced hypoglycemia. A review based on 473 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Treatment of hypercholesterolemia: comparison of younger versus older patients using wax-matrix sustained-release niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Screening for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Identification of Medications That Cause Cognitive Impairment in Older People: The Case of Oxybutynin Chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

The mental efficiency of the elderly person with type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

A randomized clinical trial of outpatient comprehensive geriatric assessment coupled with an intervention to increase adherence to recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

The prevalence of potentially remediable urinary incontinence in frail older people: a study using the Minimum Data Set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Quality indicators for the management of urinary incontinence in vulnerable community-dwelling elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Effects of a group exercise program on strength, mobility, and falls among fall-prone elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Home visits by an occupational therapist for assessment and modification of environmental hazards: a randomized trial of falls prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.51.5S.1.X

Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1056/NEJM199010113231503

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Diabetes trends in the U.S.: 1990-1998.

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Older women with diabetes have a higher risk of falls: a prospective study

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Prevalence of depression in adults with diabetes. An epidemiological evaluation

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Levels and risks of depression and anxiety symptomatology among diabetic adults

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Risk factors for fractures of the distal forearm and proximal humerus. The Study of Osteoporotic Fractures Research Group

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Diabetic neuropathy: scope of the syndrome

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Diabetic neuropathy: pathogenesis and therapy

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

24 December 2023

Acove quality indicators

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Cost-effectiveness of treating hyperlipidemia in the presence of diabetes : who should be treated?

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Antidepressant use in the elderly population in Canada: results from a national survey

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Urinary incontinence among community-dwelling people aged 40 years or older in Japan: prevalence, risk factors, knowledge and self-perception

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Fall risk index for elderly patients based on number of chronic disabilities

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Diabetes and Incidence of Functional Disability in Older Women

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease. Israeli Bezafibrate Infarction Prevention Study Group

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

A metaregression analysis of the dose-response effect of aspirin on stroke

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Anti-smoking advice for young diabetic smokers: is it a waste of breath?

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Behaviour therapy versus doctor's anti-smoking advice in diabetic patients

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. STOP Hypertension-2 Study Group.

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. This official ASHP practice standard was developed through the ASHP Commission on Therapeutics and approved by the ASHP Board of D

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Diuretics, Serum and Intracellular Electrolyte Levels, and Ventricular Arrhythmias in Hypertensive Men

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Diuretic therapy for hypertension and the risk of primary cardiac arrest

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Standards of medical care for patients with diabetes mellitus

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

The Efficacy of Self-Monitoring of Blood Glucose in NIDDM subjects: A criteria-based literature review

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Drug-induced hypoglycemic coma in 102 diabetic patients

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes?

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Undesired effects of the sulphonylurea drugs.

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Glibenclamide-associated hypoglycaemia: a report on 57 cases

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Metformin-associated lactic acidosis

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Pravastatin experience in elderly and non-elderly patients

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Reduction in coronary events during treatment with pravastatin. PLAC I and PLAC II Investigators. Pravastatin Limitation of Atherosclerosis in the Coronary Arteries

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

A randomised controlled trial of the effect of low fat diet advice on dietary response in insulin independent diabetic women

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Nutrition education and social learning interventions for type II diabetes.

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Telematic expert system Diabeto. New tool for diet self-monitoring for diabetic patients

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Dietary advice based on the glycaemic index improves dietary profile and metabolic control in type 2 diabetic patients

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

A comparison of learning activity packages and classroom instruction for diet management of patients with non-insulin-dependent diabetes mellitus

24 December 2023

100

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes.

24 December 2023

101

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction

24 December 2023

102

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial

24 December 2023

103

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Improving self-care among older patients with type II diabetes: the "Sixty Something..." Study

24 December 2023

104

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

A Randomized Controlled Trial of Weight Reduction and Exercise for Diabetes Management in Older African-American Subjects

24 December 2023

105

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Improved control of type 2 diabetes mellitus: a practical education/behavior modification program in a primary care clinic.

24 December 2023

106

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Efficacy and safety of cerivastatin for type 2 diabetes and hypercholesterolaemia. Hyperlipidaemia in Diabetes Mellitus investigators

24 December 2023

107

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings

24 December 2023

109

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Photocoagulation for Diabetic Macular Edema

24 December 2023

110

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review.

24 December 2023

112

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

24 December 2023

113

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)

24 December 2023

114

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus

24 December 2023

115

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Lower-extremity amputation in people with diabetes. Epidemiology and prevention

24 December 2023

117

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of life

24 December 2023

118

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Evaluation of a pharmaceutical care model on diabetes management

24 December 2023

119

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

A community-based, culturally sensitive education and group-support intervention for Mexican Americans with NIDDM: a pilot study of efficacy

24 December 2023

120

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Meta-analysis of the effects of educational and psychosocial interventions on management of diabetes mellitus

24 December 2023

121

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

A randomized, controlled comparison of instruction by a diabetes educator versus self-instruction in self-monitoring of blood glucose.

24 December 2023

122

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

How to improve the readability of the patient package leaflet: a survey on the use of colour, print size and layout

24 December 2023

123

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Non-compliance with drug treatment and reading difficulties with regard to prescription labelling among seniors

24 December 2023

124

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effectiveness of interventions to improve patient compliance: a meta-analysis

24 December 2023

125

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Prevention of amputation by diabetic education

24 December 2023

126

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Case-finding instruments for depression. Two questions are as good as many

24 December 2023

127

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

24 December 2023

128

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

24 December 2023

Depression and Diabetes

129

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Prevalence and costs of major depression among elderly claimants with diabetes.

24 December 2023

130

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Case-finding for depression in primary care: a randomized trial.

24 December 2023

131

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

A Randomized Trial of Office-Based Screening for Common Problems in Older Persons

24 December 2023

132

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Treatment of depression in diabetes: impact on mood and medical outcome

24 December 2023

133

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Predicting response to cognitive behavior therapy of depression in type 2 diabetes

24 December 2023

134

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial

24 December 2023

135

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Antidepressant versus placebo for depressed elderly.

24 December 2023

137

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Role of exercise stress testing and safety monitoring for older persons starting an exercise program

24 December 2023

139

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy.

24 December 2023

140

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Falls and fall prevention in the nursing home.

24 December 2023

142

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

24 December 2023

Falls in the elderly.

143

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

The epidemiology of falls and syncope.

24 December 2023

144

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Treatment of Depression in Late Life

24 December 2023

145

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Medication use and major depressive syndrome in a community population

24 December 2023

146

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Drug-induced cognitive impairment. Defining the problem and finding solutions

24 December 2023

147

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Drug-induced cognition disorders in the elderly: incidence, prevention and management

24 December 2023

149

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Drug-induced cognitive impairment in the elderly

24 December 2023

150

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Antipsychotic medications and the elderly: effects on cognition and implications for use.

24 December 2023

151

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Medications of elderly institutionalized incontinent females

24 December 2023

152

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Medications can cause or treat urinary incontinence

24 December 2023

153

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Pharmacologic causes of female incontinence

24 December 2023

154

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

The role of medications in geriatric failure to thrive

24 December 2023

156

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial

24 December 2023

157

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effect of type II diabetes mellitus on cognitive function.

24 December 2023

159

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Association of diabetes mellitus and dementia: the Rotterdam Study

24 December 2023

160

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies

24 December 2023

161

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Type 2 diabetes mellitus, cognitive impairment and dementia.

24 December 2023

162

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Diabetes mellitus and the rate of cognitive ageing

24 December 2023

163

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Why is learning and memory dysfunction in Type 2 diabetes limited to older adults?

24 December 2023

164

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study

24 December 2023

165

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

24 December 2023

“Mini-mental state”

166

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

The association of depressive symptoms and urinary incontinence among older adults

24 December 2023

170

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques.

24 December 2023

175

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

The Effect of Strength and Endurance Training on Gait, Balance, Fall Risk, and Health Services Use in Community-Living Older Adults

24 December 2023

176

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effectiveness and economic evaluation of a nurse delivered home exercise programme to prevent falls. 2: Controlled trial in multiple centres

24 December 2023

177

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Economic evaluation of a community based exercise programme to prevent falls

24 December 2023

178

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Prevention of falls in the elderly trial (PROFET): a randomised controlled trial

24 December 2023

181

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Home safety assessment in the prevention of falls among older people.

24 December 2023

182

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Effects of a programme of multifactorial home visits on falls and mobility impairments in elderly people at risk: randomised controlled trial.

24 December 2023

183

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Preventing falls in older people: outcome evaluation of a randomized controlled trial

24 December 2023

185

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Benefits of home visits for falls and autonomy in the elderly: a randomized trial study

24 December 2023

186

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

24 December 2023

187

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.51.5S.1.X